Testing version — LOERadar is in active testing. Features and data may change.
XOPENEX (LEVALBUTEROL HYDROCHLORIDE) | LOERadar
XOPENEX
NDA
LEVALBUTEROL HYDROCHLORIDE | N020837 | HIKMA PHARMACEUTICALS USA INC
4 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (4)
Sort:
#001 — EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
SOLUTION;INHALATION | Approved: Mar 25, 1999
No patent or exclusivity listings for this strength.
#002 — EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
SOLUTION;INHALATION | Approved: Mar 25, 1999
#003 — EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
SOLUTION;INHALATION | Approved: Jan 30, 2002
#004 — EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**